IMARC Group’s report titled “Veterinary Infectious Disease Diagnostics Market Report by Technology (Immunodiagnostics, Molecular Diagnostics, and Others), Animal Type (Companion Animals, Food Producing Animals), Infection Type (Bacterial Infections, Viral Infections, Parasitic Infections, and Others), End User (Reference Laboratories, Veterinary Laboratories and Clinics, Point of Care/In House Testing, Research Institutes and Universities), and Region 2024-2032” , The global veterinary infectious disease diagnostics market size reached US$ 2.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.0 Billion by 2032, exhibiting a growth rate (CAGR) of 7.4% during 2024-2032.

Factors Affecting the Growth of the Veterinary Infectious Disease Diagnostics Industry:

  • Growing Awareness of Animal Health and Welfare:

The market for veterinary infectious disease diagnostics is growing because more people are becoming aware of the importance of animal health and welfare. Pet owners are now more focused on keeping their pets healthy by using regular veterinary care and diagnostic tests. This trend is also driven by concerns about zoonotic diseases—illnesses that can spread from animals to humans. In 2024, there will likely be more focus on preventing diseases by using tests that can detect problems early, helping vets provide timely treatment. Livestock farmers are also investing in these diagnostics to protect their animals, avoid disease outbreaks, and reduce financial losses. This growing demand is boosting the use of advanced technologies like molecular tests, blood tests, and quick point-of-care solutions to improve animal health and prevent disease spread.

  • Advances in Diagnostic Technology:

New technologies are changing the way veterinarians test for infectious diseases, making it faster, more accurate, and more affordable. Tools like PCR tests, next-generation sequencing, and point-of-care diagnostics are improving how quickly and precisely diseases are detected. In 2024, these technologies are expected to improve even further, with better accuracy and the ability to detect diseases more easily. Artificial intelligence and machine learning are also being used to analyze test results, helping vets understand and act on the data more quickly. These advancements allow for early detection of new diseases and better outbreak management. As more veterinary clinics adopt these tools, the market for diagnostic solutions will continue to grow.

  • Support from Governments and Organizations:

Support from governments and health organizations is another key reason for the growth of this market. Animal health is important not only for pets and livestock but also for public health, food safety, and the economy. In 2024, more funding is expected to go into research and development for better diagnostic tools. Policies are likely to encourage the creation of faster and more accurate tests to deal with animal diseases. Public and private collaborations are also driving innovation, helping veterinarians access the latest technologies. This supportive environment is helping the market grow and improving animal health practices overall.

Leading Companies Operating in the Global Veterinary Infectious Disease Diagnostics Industry:

  • Abbott Laboratories
  • Biomérieux SA
  • Creative Diagnostics
  • HESKA Corporation
  • Innovative Diagnostics
  • IDEXX Laboratories Inc.
  • Neogen Corporation
  • Qiagen N.V.
  • Randox Laboratories Ltd
  • Thermo Fisher Scientific Inc
  • Virbac., etc.

Veterinary Infectious Disease Diagnostics Market Report Segmentation:

Breakup by Technology:

  • Immunodiagnostics
  • Molecular Diagnostics
  • Others

Breakup by Animal Type:

  • Companion Animals
  • Food Producing Animals

Breakup by Infection Type:

  • Bacterial Infections
  • Viral Infections
  • Parasitic Infections
  • Others

Breakup by End User:

  • Reference Laboratories
  • Veterinary Laboratories and Clinics
  • Point of Care/In House Testing
  • Research Institutes and Universities

Regional Insights:

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa

Veterinary Infectious Disease Diagnostics Market Trends:

The veterinary diagnostics market is changing in exciting ways. One big trend is the rise of telemedicine and remote diagnostics, which let vets consult experts and use diagnostic tools without being limited by location. In 2024, this trend will grow as digital tools become more common, making it easier to diagnose and treat animals quickly. Rapid testing will also become more popular, reducing the time it takes to get results and start treatment. Personalized medicine, where diagnostic tests are tailored to an individual animal’s needs, will also grow. With more people owning pets and prioritizing their health, the demand for advanced diagnostics will continue to rise. In 2024, this market will reflect a mix of new technology, better access to care, and a stronger focus on animal welfare and public health.

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us

IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1–631–791–1145